STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia

NCT05490563 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class

Stopped This was a business decision due to financial considerations, not based on data related to safety or therapeutic effects.

Conditions

Interventions

Sponsor

Seelos Therapeutics, Inc.